Royal Pharmaceutical Society (RPS) - News updates

Certain pages on this news feed are only available to RPS members and hence requires members to log-in accordingly

Levomepromazine 25mg/ml injection supply issue (urgent) – information for primary care from the Department of Health & Social Care (DHSC)

Overview of Supply • Sanofi informed NHS England and DHSC on 5th April 2019 that they are going out of stock this week of levomepromazine 25mg/ml injection and new stock is expected to be availa

Class 4 Medicines Defect Information: chloramphenicol 0.5% W/V antibiotic eye drops

Martindale Pharmaceuticals has informed the MHRA of two issues with all unexpired batches of chloramphenicol 0.5% W/V antibiotic eye drops (PL 00156/0109), legal status ‘P’.

Company-led recall: Nutriflex Omega Special 2500ml

B. Braun Medical Ltd is recalling specific batches of Nutriflex Omega Special 2500ml PL 03551/0118 as ongoing stability studies have identified that they may have an out of specification result in the

Candidates announced for the RPS National Board Elections 2019

We are delighted to announce we have had a total of 21nominations for this year’s RPS National Pharmacy Board elections. For the English Pharmacy Board election, we have received 11nominations.

We welcome new Pharmacy Minister

The Department of Health and Social Carehas confirmed the appointment of Seema Kennedy as the new Parliamentary Under Secretary of State for Public Health and Primary Care, with responsibility for pha

Our Museum wins Arts Council Accreditation!

We're thrilled to announce that the RPS Museum has retained Full Accreditation from Arts Council England in our latest review. The scheme is the professional standard for museums and galleries in

Class 4 medicine defect information: zoledronic acid 5mg solution for infusion

Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed the MHRA that some packs from a batch of zoledronic acid 5mg solution for infusion contain a patient information leaflet for temozolomide 18

Ambitious vision for pharmacy education will fail without funding

We’ve published our response link to the General Pharmaceutical Council’s consultation on initial education and training standards for pharmacists. The consultation makes a number of prop

Medicines with teratogenic potential: what is effective contraception and how often is pregnancy testing needed?

New guidance on contraceptive methods and frequency of pregnancy testing to reduce inadvertent exposures during pregnancy....

RPS Welcomes Welsh Government investment in Community Pharmacy

A recent announcement by the Welsh Government to make an increase in community pharmacy funding of £1.4m in 2018-19 has been warmly welcomed by the Royal Pharmaceutical Society. Responding to t